Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Risk adjusted net present value: What is the current valuation of Roche's Divarasib?
Divarasib is a small molecule commercialized by Roche, with a leading Phase III program in Non-Small Cell Lung Cancer. According...
Divarasib by Genentech USA for Solid Tumor: Likelihood of Approval
Divarasib is under clinical development by Genentech USA and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
Divarasib by Genentech USA for Pancreatic Cancer: Likelihood of Approval
Divarasib is under clinical development by Genentech USA and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase...